Ratings Taaleri Oyj

Equities

TAALA

FI4000062195

Market Closed - Nasdaq Helsinki Other stock markets 12:00:00 2024-07-12 pm EDT			5-day change	1st Jan Change
8.25 ^EUR	+0.73%		-0.48%	-8.23%

May. 22	EniferBio announced that it has received ?22 million in funding from Taaleri Oyj, Taaleri Bioindustry, Voima Ventures, Valio Ltd, The Finnish Climate Fund, Nordic Food Tech Venture Capital Oy, and another investor	CI
May. 07	Transcript : Taaleri Oyj, Q1 2024 Earnings Call, May 07, 2024

Strengths

The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
Thanks to a sound financial situation, the firm has significant leeway for investment.
With a P/E ratio at 8.71 for the current year and 11.58 for next year, earnings multiples are highly attractive compared with competitors.
The company has a low valuation given the cash flows generated by its activity.
This company will be of major interest to investors in search of a high dividend stock.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
For the past twelve months, EPS forecast has been revised upwards.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
Most analysts recommend that the stock should be sold or reduced.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Over the past twelve months, analysts' opinions have been revised negatively.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Investment Management & Fund Operators

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
TAALERI OYJ	-8.23%	254M		-
BLACKROCK, INC.	+1.99%	123B		A-
BROOKFIELD CORPORATION	+18.02%	71.42B	-	B+
APOLLO GLOBAL MANAGEMENT, INC.	+29.35%	68.59B		C
BANK OF NEW YORK MELLON CORPORATION (THE)	+24.28%	48.38B		C+
AMERIPRISE FINANCIAL, INC.	+17.49%	44.33B		A-
3I GROUP PLC	+24.58%	37.78B		A-
T. ROWE PRICE GROUP INC.	+9.59%	26.35B		B
STATE STREET CORPORATION	+1.42%	23.67B		A-
PRINCIPAL FINANCIAL GROUP, INC.	+7.92%	19.91B		B+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes